Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06856148 · ClinicalTrials.gov registry record · NA
Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
A NA study of Substance Use Disorders and Substance Abuse, sponsored by Penn State University.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT06856148: Recruiting NA study of Substance Use Disorders and Substance Abuse, sponsored by Penn State University.
NCT06856148 is a NA study of Substance Use Disorders and Substance Abuse that is actively recruiting participants, run by Penn State University. The registered enrollment target is 300 participants, below the 497-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (40% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06856148, a NA study of Substance Use Disorders and Substance Abuse, is actively recruiting participants, sponsored by Penn State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
If science is to inform effective substance misuse prevention policy and ultimately improve public health, the field needs an effective strategy for directly supporting policymakers' use of research evidence, yet our field lacks an evidence-based model designed for this purpose. Accordingly, a state-level randomized controlled trial (N = 30 states) of a formal, theory-based approach for appropriately supporting policymakers' use of scientific evidence--known as the Research-to-Policy Collaboration (RPC) Model is proposed. This work has the potential to reduce population-level substance misuse by improving the use of scientific information in policymaking, thus increasing the availability of evidence-based prevention programs and policies.
Primary Outcome
Assessment of use of research evidence in bills introduced during the intervention period. It is anticipated that legislators will introduce over 5,000 bills relating to substance use are. These bills will be coded for presence of evidence markers using a validated, deductive codebook to identify how legislators use research evidence in legislative language. A subset of these bills (N = 150) will be reviewed by trained coders to identify the form (i.e. direct or indirect) and the goal of evidenc
Conditions Studied
Interventions
- BEHAVIORAL Intervention: RPC Group
- BEHAVIORAL Active Comparator: Control Group
Study Locations (1)
Pennsylvania
- Penn State University - University Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2023-04-01 |
| Est. Completion | 2027-03-31 |
| Phase | NA |
What NCT06856148 shows while recruiting
NCT06856148 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 497-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (40% lower).
The record links to 5 conditions, with Substance Use Disorders appearing as the primary indexed condition, and to 2 interventions - of which Intervention: RPC Group is the first listed.
NCT06856148 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06856148 about?
NCT06856148 is a clinical study titled "Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts". If science is to inform effective substance misuse prevention policy and ultimately improve public health, the field needs an effective strategy for directly supporting policymakers' use of research evidence, yet our field lacks an evidence-based model designed for this purpose. Accordingly, a state...
What is the current status of trial NCT06856148?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2023-04-01. Estimated completion is 2027-03-31.
What conditions does trial NCT06856148 study?
This clinical trial studies the following conditions: Substance Use Disorders, Substance Abuse, Prevention, Legislation, Use of Research Evidence.
What interventions are being tested in trial NCT06856148?
The interventions under investigation include: Intervention: RPC Group (BEHAVIORAL), Active Comparator: Control Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT06856148?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06856148 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06856148's enrollment target sits among peer trials
300 18th of 93 higher than 74 of 93 other Substance Use Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Supporting Treatment Access and Recovery Through Linkage and Support
RECRUITING · NA
-
Development OF A Novel Peer Recovery Supporter Training Platform
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Families Left Behind
RECRUITING · NA
-
Trauma Screening/Referral and Interpersonal Violence Prevention for Women with Substance Use Disorders
RECRUITING · NA
-
The Oklahoma Parent-Child Assistance Program
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI